Skip to main content

Table 2 Multivariate analyses of prognostic factors for OS of stage III gastric cancer

From: Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer

Variables

Analysis with CAR

Analysis with NLR

Analysis with PLR

Analysis with PNI

Analysis with GPS

HR (95% CI)

p value

HR (95% CI)

p value

HR (95% CI)

p value

HR (95% CI)

p value

HR (95% CI)

p value

Age (years)

  ≤ 68

1

 

1

 

1

 

1

 

1

 

  > 68

1.245 (0.832–1.862)

0.287

1.303 (0.878–1.935)

0.189

1.354 (0.910–2.014)

0.135

1.284 (0.851–1.937)

0.234

1.298 (0.871–1.934)

0.200

Performance status

 0

1

 

1

 

1

 

1

 

1

 

 1–3

1.246 (0.793–1.957)

0.340

1.311 (0.843–2.039)

0.229

1.320 (0.852–2.046)

0.214

1.333 (0.857–2.073)

0.202

1.318 (0.847–2.051)

0.221

Location

 Upper/Middle/Lower

1

 

1

 

1

 

1

 

1

 

 Whole

1.097 (0.882–1.364)

0.406

1.079 (0.866–1.345)

0.497

1.079 (0.867–1.343)

0.496

1.095 (0.880–1.362)

0.417

1.090 (0.876–1.358)

0.439

Operative procedure

 Distal gastrectomy

1

 

1

 

1

 

1

 

1

 

 Total gastrectomy

1.765 (1.201–2.595)

0.004

1.657 (1.138–2.413)

0.008

1.753 (1.195–2.573)

0.004

1.654 (1.132–2.417)

0.009

1.660 (1.136–2.425)

0.009

TNM sub-stage

 IIIA

1

0.060

1

0.048

1

0.034

1

0.066

1

0.063

 IIIB

1.511 (0.972–2.348)

0.067

1.481 (0.953–2.300)

0.081

1.531 (0.983–2.382)

0.059

1.487 (0.953–2.321)

0.081

1.495 (0.962–2.323)

0.074

 IIIC

1.694 (1.074–2.671)

0.023

1.754 (1.111–2.768)

0.016

1.812 (1.146–2.865)

0.011

1.707 (1.074–2.714)

0.024

1.702 (1.074–2.697)

0.024

Tumor size (mm)

  ≤ 60

1

 

1

 

1

 

1

 

1

 

  > 60

1.017 (0.689–1.501)

0.933

1.065 (0.726–1.561)

0.749

0.983 (0.663–1.457)

0.931

1.058 (0.717–1.561)

0.776

1.054 (0.715–1.554)

0.791

Adjuvant chemotherapy

 Absent

1

 

1

 

1

 

1

 

1

 

 Present

0.807 (0.507–1.284)

0.366

0.810 (0.509–1.288)

0.373

0.772 (0.486–1.227)

0.274

0.797 (0.501–1.267)

0.337

0.806 (0.508–1.281)

0.361

CAR

 Low (≤0.47)

1

         

 High (> 0.47)

2.257 (1.180–4.319)

0.014

        

NLR

 Low (≤1.90)

  

1

       

 High (> 1.90)

  

1.322 (0.926–1.887)

0.124

      

PLR

 Low (≤172)

    

1

     

 High (> 172)

    

1.478 (1.025–2.133)

0.037

    

PNI

 Low (≤45.6)

      

1

   

 High (> 45.6)

      

0.922 (0.631–1.348)

0.676

  

GPS

 0

        

1

 

 1/2

        

1.141 (0.754–1.727)

0.533

  1. TNM tumor-node-metastasis, CAR C-reactive protein/Albumin ratio, NLR neutrophil to lymphocyte ratio, PLR platelet to lymphocyte ratio, PNI Prognostic Nutritional Index, GPS Glasgow Prognostic Score